The world is our oyster with NNZ-2591 and its treasure trove, but for heavens sake let’s not marginalise what trofinetide has done for this company and more importantly the Rett community!
FDA approval is very, very hard earned.
The substantive and significant benefits of Daybue should not be trivialised.
The FIRST TREATMENT EVER to be able to benefit the Rett community worldwide. No hope, no treatment at all prior to this breakthrough.
I am supremely excited at our prospective pipeline with NNZ-2591 and the advancements it can achieve.
I don’t believe though that we need to treat our high achiever first child with any level of disrespect.
The world is our oyster with NNZ-2591 and its treasure trove,...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |